Singapore, June 4 -- BioNet, a Franco-Thai vaccine biotech group, and PT Bio Farma (Persero),Indonesia'sstate-owned vaccine manufacturer, have signed a Memorandum of Understanding (MoU) to collaborate on development and regional distribution of a combined TdaP vaccine (tetanus, diphtheria, and acellular recombinant pertussis).

The partnership combines BioNet's proprietary recombinant pertussis technology and global clinical experience with Bio Farma's large-scale manufacturing and public health reach to address critical immunisation needs in ASEAN (Association of Southeast Asian Nations).

The MoU outlines cooperation in clinical development, regulatory alignment, and market access. Bio Farma leads clinical trials and regulatory submissi...